Literature DB >> 15759080

Natural cytotoxicity receptors: pattern recognition and involvement of carbohydrates.

Angel Porgador1.   

Abstract

Natural cytotoxicity receptors (NCRs), expressed by natural killer (NK) cells, trigger NK lysis of tumor and virus-infected cells on interaction with cell-surface ligands of these target cells. We have determined that viral hemagglutinins expressed on the surface of virus-infected cells are involved in the recognition by the NCRs, NKp44 and NKp46. Recognition of tumor cells by the NCRs NKp30 and NKp46 involves heparan sulfate epitopes expressed on the tumor cell membrane. Our studies provide new evidence for the identity of the ligands for NCRs and indicate that a broader definition should be applied to pathological patterns recognized by innate immune receptors. Since nonmicrobial endogenous carbohydrate structures contribute significantly to this recognition, there is an imperative need to develop appropriate tools for the facile sequencing of carbohydrate moieties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759080      PMCID: PMC5936559          DOI: 10.1100/tsw.2005.22

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  7 in total

1.  NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.

Authors:  Michal Mendelson; Yoram Tekoah; Alon Zilka; Orly Gershoni-Yahalom; Roi Gazit; Hagit Achdout; Nicolai V Bovin; Tal Meningher; Michal Mandelboim; Ofer Mandelboim; Ayelet David; Angel Porgador
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

2.  Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Authors:  Paul E Leon; Wenqian He; Caitlin E Mullarkey; Mark J Bailey; Matthew S Miller; Florian Krammer; Peter Palese; Gene S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

3.  NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.

Authors:  Oren Hershkovitz; Benyamin Rosental; Lior Ann Rosenberg; Martha Erika Navarro-Sanchez; Sergey Jivov; Alon Zilka; Orly Gershoni-Yahalom; Elodie Brient-Litzler; Hugues Bedouelle; Joanna W Ho; Kerry S Campbell; Bracha Rager-Zisman; Philippe Despres; Angel Porgador
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

Review 4.  The use of microRNA by human viruses: lessons from NK cells and HCMV infection.

Authors:  Tal Goldberger; Ofer Mandelboim
Journal:  Semin Immunopathol       Date:  2014-09-19       Impact factor: 11.759

5.  Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Authors:  Tal I Arnon; Gal Markel; Ahuva Bar-Ilan; Jacob Hanna; Eyal Fima; Fabrice Benchetrit; Ruth Galili; Adelheid Cerwenka; Daniel Benharroch; Netta Sion-Vardy; Angel Porgador; Ofer Mandelboim
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

6.  Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.

Authors:  Yonat Shemer-Avni; Kiran Kundu; Avishai Shemesh; Michael Brusilovsky; Rami Yossef; Mesfin Meshesha; Semaria Solomon-Alemayehu; Shai Levin; Orly Gershoni-Yahalom; Kerry S Campbell; Angel Porgador
Journal:  Front Immunol       Date:  2017-02-15       Impact factor: 7.561

Review 7.  Tumor-Associated Glycans and Immune Surveillance.

Authors:  Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Vaccines (Basel)       Date:  2013-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.